MedMira Inc. Stock

Equities

MIR

CA58501R1029

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 09:30:00 2024-04-22 am EDT 5-day change 1st Jan Change
0.075 CAD 0.00% Intraday chart for MedMira Inc. -16.67% -31.82%
Sales 2022 952K 695K Sales 2023 433K 316K Capitalization 59.28M 43.29M
Net income 2022 -1M -730K Net income 2023 -2M -1.46M EV / Sales 2022 101 x
Net Debt 2022 8.77M 6.4M Net Debt 2023 10.03M 7.33M EV / Sales 2023 160 x
P/E ratio 2022
-41.7 x
P/E ratio 2023
-21.3 x
Employees 52
Yield 2022 *
-
Yield 2023
-
Free-Float 29.44%
More Fundamentals * Assessed data
Dynamic Chart
1 week-16.67%
Current month-11.76%
1 month-16.67%
3 months-25.00%
6 months-28.57%
Current year-31.82%
More quotes
1 week
0.07
Extreme 0.07
0.08
1 month
0.07
Extreme 0.07
0.09
Current year
0.07
Extreme 0.07
0.12
1 year
0.07
Extreme 0.07
0.14
3 years
0.05
Extreme 0.05
0.28
5 years
0.00
Extreme 0
0.89
10 years
0.00
Extreme 0
0.89
More quotes
Managers TitleAgeSince
Founder - 92-12-31
Director of Finance/CFO - 10-01-27
Director/Board Member 60 07-04-30
Members of the board TitleAgeSince
Founder - 92-12-31
Director/Board Member 60 07-04-30
Director of Finance/CFO - 10-01-27
More insiders
Date Price Change Volume
24-04-22 0.075 0.00% 9,000
24-04-19 0.075 -6.25% 186,181
24-04-18 0.08 0.00% 8,003
24-04-17 0.08 -5.88% 64,000

Delayed Quote Toronto S.E., April 22, 2024 at 09:30 am EDT

More quotes
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.
More about the company